Seon, Ben K.
https://orcid.org/0009-0003-8765-679X
Mayo Clinic
Roswell Park Comprehensive Cancer Center
Citations 2
A phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) in combination with pazopanib in patients with advanced soft tissue sarcoma (STS).
Attia, Steven , Conry, Robert M. , Sankhala, Kamalesh K. , Seon, Ben K. , Alvarez, Delia, Adams, Bonne J., Theuer, Charles P. , Riedel, Richard F. , Robinson, Steven I. , Maki, Robert G.
Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 10514-10514
A phase 1B/ phase 2A study of TRC105 (Endoglin Antibody) in combination with pazopanib (P) in patients (pts) with advanced soft tissue sarcoma (STS).
Attia, Steven , Sankhala, Kamalesh K. , Riedel, Richard F. , Conry, Robert M. , Fritchie, Karen , Seon, Ben K. , Alvarez, Delia, Adams, Bonne J., Shazer, Ronald , Theuer, Charles P. , Maki, Robert G. , Maki, Robert G , Riedel, Richard F , Robinson, Steven I. , Boland, Patrick M. , Barve, Minal
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 11016-11016